Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 985 to 988 of 988 entries
Sorted by: Best Match Show Resources per page
Systematic Review of Racial, Socioeconomic, and Insurance Status Disparities in the Treatment of Pediatric Neurosurgical Diseases in the United States.

World neurosurgery

Lechtholz-Zey E, Bonney PA, Cardinal T, Mendoza J, Strickland BA, Pangal DJ, Giannotta S, Durham S, Zada G.
PMID: 34718199
World Neurosurg. 2021 Oct 27;158:65-83. doi: 10.1016/j.wneu.2021.10.150. Epub 2021 Oct 27.

BACKGROUND: Increasing light is being shed on how race, insurance, and socioeconomic status (SES) may be related to outcomes from disease in the United States. To better understand the impact of these health care disparities in pediatric neurosurgery, we...

Cite
Lechtholz-Zey E, Bonney PA, Cardinal T, et al. Systematic Review of Racial, Socioeconomic, and Insurance Status Disparities in the Treatment of Pediatric Neurosurgical Diseases in the United States. World Neurosurg. 2021;158:65-83doi: 10.1016/j.wneu.2021.10.150.
Lechtholz-Zey, E., Bonney, P. A., Cardinal, T., Mendoza, J., Strickland, B. A., Pangal, D. J., Giannotta, S., Durham, S., & Zada, G. (2021). Systematic Review of Racial, Socioeconomic, and Insurance Status Disparities in the Treatment of Pediatric Neurosurgical Diseases in the United States. World neurosurgery, 15865-83. https://doi.org/10.1016/j.wneu.2021.10.150
Lechtholz-Zey, Elizabeth, et al. "Systematic Review of Racial, Socioeconomic, and Insurance Status Disparities in the Treatment of Pediatric Neurosurgical Diseases in the United States." World neurosurgery vol. 158 (2021): 65-83. doi: https://doi.org/10.1016/j.wneu.2021.10.150
Lechtholz-Zey E, Bonney PA, Cardinal T, Mendoza J, Strickland BA, Pangal DJ, Giannotta S, Durham S, Zada G. Systematic Review of Racial, Socioeconomic, and Insurance Status Disparities in the Treatment of Pediatric Neurosurgical Diseases in the United States. World Neurosurg. 2021 Oct 27;158:65-83. doi: 10.1016/j.wneu.2021.10.150. Epub 2021 Oct 27. PMID: 34718199.
Copy Download .nbib Format: NLM
Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination.

Nature

Cho A, Muecksch F, Schaefer-Babajew D, Wang Z, Finkin S, Gaebler C, Ramos V, Cipolla M, Mendoza P, Agudelo M, Bednarski E, DaSilva J, Shimeliovich I, Dizon J, Daga M, Millard KG, Turroja M, Schmidt F, Zhang F, Tanfous TB, Jankovic M, Oliveria TY, Gazumyan A, Caskey M, Bieniasz PD, Hatziioannou T, Nussenzweig MC.
PMID: 34619745
Nature. 2021 Dec;600(7889):517-522. doi: 10.1038/s41586-021-04060-7. Epub 2021 Oct 07.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection produces B cell responses that continue to evolve for at least a year. During that time, memory B cells express increasingly broad and potent antibodies that are resistant to mutations found...

Cite
Cho A, Muecksch F, Schaefer-Babajew D, et al. Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination. Nature. 2021;600(7889):517-522doi: 10.1038/s41586-021-04060-7.
Cho, A., Muecksch, F., Schaefer-Babajew, D., Wang, Z., Finkin, S., Gaebler, C., Ramos, V., Cipolla, M., Mendoza, P., Agudelo, M., Bednarski, E., DaSilva, J., Shimeliovich, I., Dizon, J., Daga, M., Millard, K. G., Turroja, M., Schmidt, F., Zhang, F., Tanfous, T. B., Jankovic, M., Oliveria, T. Y., Gazumyan, A., Caskey, M., Bieniasz, P. D., Hatziioannou, T., & Nussenzweig, M. C. (2021). Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination. Nature, 600(7889), 517-522. https://doi.org/10.1038/s41586-021-04060-7
Cho, Alice, et al. "Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination." Nature vol. 600,7889 (2021): 517-522. doi: https://doi.org/10.1038/s41586-021-04060-7
Cho A, Muecksch F, Schaefer-Babajew D, Wang Z, Finkin S, Gaebler C, Ramos V, Cipolla M, Mendoza P, Agudelo M, Bednarski E, DaSilva J, Shimeliovich I, Dizon J, Daga M, Millard KG, Turroja M, Schmidt F, Zhang F, Tanfous TB, Jankovic M, Oliveria TY, Gazumyan A, Caskey M, Bieniasz PD, Hatziioannou T, Nussenzweig MC. Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination. Nature. 2021 Dec;600(7889):517-522. doi: 10.1038/s41586-021-04060-7. Epub 2021 Oct 07. PMID: 34619745.
Copy Download .nbib Format: NLM
Correlation of Automated Chemiluminescent Method with Enzyme-Linked Immunosorbent Assay (ELISA) Antibody Titers in Convalescent COVID-19 Plasma Samples: Development of Rapid, Cost-Effective Semi-Quantitative Diagnostic Methods.

Journal of blood medicine

Mendoza R, Silver M, Zuretti AR, Christian M, Das B, Norin AJ, Borgen P, Libien J, Bluth MH.
PMID: 33762863
J Blood Med. 2021 Mar 17;12:157-164. doi: 10.2147/JBM.S296730. eCollection 2021.

BACKGROUND: We investigated the utility of an automated chemiluminescent SARS-CoV-2 IgG antibody assay platform in quantifying the amount of binding antibodies present in donated convalescent plasma.METHODS: A total of 179 convalescent plasma units were analyzed for the presence of...

Cite
Mendoza R, Silver M, Zuretti AR, et al. Correlation of Automated Chemiluminescent Method with Enzyme-Linked Immunosorbent Assay (ELISA) Antibody Titers in Convalescent COVID-19 Plasma Samples: Development of Rapid, Cost-Effective Semi-Quantitative Diagnostic Methods. J Blood Med. 2021;12:157-164doi: 10.2147/JBM.S296730.
Mendoza, R., Silver, M., Zuretti, A. R., Christian, M., Das, B., Norin, A. J., Borgen, P., Libien, J., & Bluth, M. H. (2021). Correlation of Automated Chemiluminescent Method with Enzyme-Linked Immunosorbent Assay (ELISA) Antibody Titers in Convalescent COVID-19 Plasma Samples: Development of Rapid, Cost-Effective Semi-Quantitative Diagnostic Methods. Journal of blood medicine, 12157-164. https://doi.org/10.2147/JBM.S296730
Mendoza, Rachelle, et al. "Correlation of Automated Chemiluminescent Method with Enzyme-Linked Immunosorbent Assay (ELISA) Antibody Titers in Convalescent COVID-19 Plasma Samples: Development of Rapid, Cost-Effective Semi-Quantitative Diagnostic Methods." Journal of blood medicine vol. 12 (2021): 157-164. doi: https://doi.org/10.2147/JBM.S296730
Mendoza R, Silver M, Zuretti AR, Christian M, Das B, Norin AJ, Borgen P, Libien J, Bluth MH. Correlation of Automated Chemiluminescent Method with Enzyme-Linked Immunosorbent Assay (ELISA) Antibody Titers in Convalescent COVID-19 Plasma Samples: Development of Rapid, Cost-Effective Semi-Quantitative Diagnostic Methods. J Blood Med. 2021 Mar 17;12:157-164. doi: 10.2147/JBM.S296730. eCollection 2021. PMID: 33762863; PMCID: PMC7982562.
Copy Download .nbib Format: NLM
Optical character recognition system for Baybayin scripts using support vector machine.

PeerJ. Computer science

Pino R, Mendoza R, Sambayan R.
PMID: 33817010
PeerJ Comput Sci. 2021 Feb 15;7:e360. doi: 10.7717/peerj-cs.360. eCollection 2021.

In 2018, the Philippine Congress signed House Bill 1022 declaring the Baybayin script as the Philippines' national writing system. In this regard, it is highly probable that the Baybayin and Latin scripts would appear in a single document. In...

Cite
Pino R, Mendoza R, Sambayan R. Optical character recognition system for Baybayin scripts using support vector machine. PeerJ Comput Sci. 2021;7:e360doi: 10.7717/peerj-cs.360.
Pino, R., Mendoza, R., & Sambayan, R. (2021). Optical character recognition system for Baybayin scripts using support vector machine. PeerJ. Computer science, 7e360. https://doi.org/10.7717/peerj-cs.360
Pino, Rodney, et al. "Optical character recognition system for Baybayin scripts using support vector machine." PeerJ. Computer science vol. 7 (2021): e360. doi: https://doi.org/10.7717/peerj-cs.360
Pino R, Mendoza R, Sambayan R. Optical character recognition system for Baybayin scripts using support vector machine. PeerJ Comput Sci. 2021 Feb 15;7:e360. doi: 10.7717/peerj-cs.360. eCollection 2021. PMID: 33817010; PMCID: PMC7959605.
Copy Download .nbib Format: NLM
Showing 985 to 988 of 988 entries